Embed Size (px)
Citation preview
Company Name Sector Amount (in
Million USD)
Type of Round
Financing Stage
Ownership Country
Machavert Pharmaceuticals
Biotechnology - Therapeutics and
Diagnostics
2.20 Series A / 1. Round
n/a Private / independent
USA
RootPath Genomics Biotechnology - Therapeutics and
Diagnostics
7.00 Other Equity (private)
Private / independent
USA
Lunaphore Technologies SA
Biotechnology / R&D Services
5.36 Series B / 2. Round
Equity (private)
Private / independent
Switzerland
Genomics plc Biotechnology / R&D Services
32.18 Series B / 2. Round
Equity (private)
Private / independent
United Kingdom
Jacobio Pharmaceuticals (also known as Beijing Jiakesi New Drug Development Co., Ltd.)
Biotechnology - Therapeutics and
Diagnostics
55.00 Series C / 3. Round
n/a Private / independent
China (Mainland)
KaNDy Therapeutics Biotechnology - Therapeutics and
Diagnostics
32.18 Series C / 3. Round
Other Private / independent
United Kingdom
Madam Therapeutics BV
Biotechnology - Therapeutics and
Diagnostics
1.27 Other Other Private / independent
Netherlands
Tempus Labs Biotechnology / R&D Services
110.00 Series E / 5. Round
Equity (private)
Private / independent
USA
Nebula Genomics Biotechnology / R&D Services
4.30 Other Equity (private)
Private / independent
USA
Outset Medical Medical Technology 132.00 Series D / 4.
Round
Equity (private)
Private / independent
USA
SAB Biotherapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
10.00 Series A / 1. Round
Equity (private)
Private / independent
USA
PhagoMed Biopharma GmbH
Biotechnology - Therapeutics and
Diagnostics
4.62 Other Equity (private)
Private / independent
Austria
Harbour BioMed Biotechnology - Therapeutics and
Diagnostics
85.00 Series B / 2. Round
n/a Private / independent
China (Mainland)
ProteoMediX AG Biotechnology / R&D Services
5.26 Other Equity (private)
Private / independent
Switzerland
Progenerative Medical
Medical Technology 1.50 Other Other Private / independent
USA
Piccolo Medical Medical Technology 2.30 Other Other Private / independent
USA
Spinal Stabilization Technologies, LLC
Medical Technology 11.00 Other Other Private / independent
USA
Formation Biologics Biotechnology - Therapeutics and
Diagnostics
18.80 Other Research grants
Private / independent
USA
ApoGen Biotechnologies Inc.
Biotechnology - Therapeutics and
Diagnostics
4.00 Series A / 1. Round
Equity (private)
Private / independent
USA
Ironshore Pharmaceuticals & Development, Inc.
Biotechnology - Therapeutics and
Diagnostics
143.00 00-Jan-00
n/a Private / independent
Other
Rakuten Aspyrian Biotechnology - Therapeutics and
Diagnostics
150.00 Series C / 3. Round
Equity (private)
Subsidiary USA
nView medical Medical Technology 1.20 Other Other Private / independent
USA
Novaremed AG Biotechnology - Therapeutics and
Diagnostics
6.07 Other Equity (private)
Private / independent
Switzerland
Sierra Oncology, Inc. Biotechnology - Therapeutics and
Diagnostics
15.00 0 n/a Publicly listed on stock exchange
Canada
410 Medical Medical Technology 3.10 Other Other Private / independent
USA
Exicure Inc. Biotechnology - Therapeutics and
Diagnostics
22.00 Other Other Private / independent
USA
Aevi Genomic Medicine, Inc.
Biotechnology - Therapeutics and
Diagnostics
4.90 0 Post-IPO Publicly listed on stock exchange
USA
Renovia Inc.™ Medical Technology 42.30 Series B / 2. Round
Equity (private)
Private / independent
USA
IntriCon Medical Technology 94.90 Other Post-IPO Private / independent
USA
Recombinetics, Inc. Biotechnology - other
34.00 Series A / 1. Round
Equity (private)
Private / independent
USA
MBio Diagnostics, Inc.
Biotechnology / R&D Services
6.00 Series B / 2. Round
Other Private / independent
USA
BioNano Genomics, Inc.
Biotechnology / R&D Services
20.60 Other IPO Publicly listed on stock exchange
USA
NeoTherma Oncology
Medical Technology 6.00 Series A / 1. Round
Equity (private)
Private / independent
USA
ViewRay, Inc. Medical Technology 173.00 Other Other Publicly listed on stock exchange
USA
IntriCon Medical Technology 89.00 Series G / 7.
Round
Other Private / independent
USA
ValenTx, Inc Medical Technology 10.30 Other Other Private / independent
USA
Pain Therapeutics, Inc.
Biotechnology - Therapeutics and
Diagnostics
10.19 Other n/a Publicly listed on stock exchange
USA
HEC Pharmaceutical (Formerly Yichang HEC Changjiang Pharmaceutical Co., Ltd.)
Pharma 400.00 0 Convertible loan
Publicly listed on stock exchange
China (Mainland)
Second Sight Medical Products, Inc.
Medical Technology 5.00 Other Other Publicly listed on stock exchange
USA
Krystal Biotech, Inc. Biotechnology - Therapeutics and
Diagnostics
10.00 Other n/a Publicly listed on stock exchange
USA
Capillary Biomedical, Inc.
Medical Technology 2.90 Other Other Private / independent
USA
Blueberry Therapeutics Ltd.
Biotechnology - Therapeutics and
Diagnostics
12.87 Series B / 2. Round
Equity (private)
Private / independent
United Kingdom
Paragen Bio Pty Ltd Biotechnology - Therapeutics and
Diagnostics
4.40 Other Other Private / independent
Australia
Profusa, Inc. Medical Technology 45.00 Series C / 3. Round
Equity (private)
Private / independent
USA
Pneuma Respiratory Pharma 10.00 Other Other Private / independent
USA
REGENXBIO Inc. Biotechnology - Therapeutics and
Diagnostics
201.80 Other Post-IPO Publicly listed on stock exchange
USA
Magnolia Neurosciences Corporation
Biotechnology - Therapeutics and
Diagnostics
31.00 Series A / 1. Round
Other Private / independent
USA
Bioasis Technologies, Inc.
Biotechnology - Therapeutics and
Diagnostics
0.97 Other Other Publicly listed on stock exchange
Canada
Orchard Therapeutics Limited
Biotechnology - Therapeutics and
Diagnostics
150.00 Series C / 3. Round
Equity (private)
Private / independent
United Kingdom
BUGWORKS Research India Pvt. Ltd.
Biotechnology - Therapeutics and
Diagnostics
9.00 Series A / 1. Round
Other Private / independent
India
Artios Pharma Limited
Biotechnology - Therapeutics and
Diagnostics
83.66 Series B / 2. Round
Equity (private)
Private / independent
United Kingdom
Co-Diagnostics Inc. Biotechnology - Therapeutics and
Diagnostics
2.00 Other Debt financing
Publicly listed on stock exchange
USA
NeoGenomics Inc. Biotechnology / R&D Services
125.00 Other Post-IPO Publicly listed on stock exchange
USA
BioElectron Technology Corporation
Biotechnology - Therapeutics and
Diagnostics
40.00 Other Other Private / independent
USA
Aequus Pharmaceuticals, Inc.
Biotechnology - Therapeutics and
Diagnostics
0.78 Other Equity (private)
Publicly listed on stock exchange
Canada
Modulus Discovery, Inc.
Biotechnology - Therapeutics and
Diagnostics
7.21 0 n/a Private / independent
Japan
Akili Interactive Labs, Inc
Biotechnology / R&D Services
13.00 Series C / 3. Round
Equity (private)
Subsidiary USA
Vaccinex, Inc Biotechnology - Therapeutics and
Diagnostics
40.00 0 IPO Publicly listed on stock exchange
USA
Newomics, Inc Biotechnology / R&D Services
3.90 Series A / 1. Round
Equity (private)
Private / independent
USA
Therachon AG Biotechnology - Therapeutics and
Diagnostics
60.00 0 n/a Private / independent
Switzerland
SQZ Biotechnologies Biotechnology - Therapeutics and
Diagnostics
72.00 Series C / 3. Round
Equity (private)
Private / independent
USA
EdiGene China Biotechnology / R&D Services
15.00 Series B / 2. Round
n/a Private / independent
China (Mainland)
TOT Biopham Co., Ltd.
Pharma 102.00 Series B / 2. Round
n/a Subsidiary China (Mainland)
Apexigen, Inc Biotechnology - Therapeutics and
Diagnostics
73.00 Series C / 3. Round
Equity (private)
Private / independent
USA
DNALite Therapeutics, Inc.
Biotechnology - Therapeutics and
Diagnostics
1.50 Other Other Private / independent
USA
Ambys Medicines Biotechnology - Therapeutics and
Diagnostics
140.00 Other Other Private / independent
USA
PRAXIS BIORESEARCH LLC
Biotechnology - Therapeutics and
Diagnostics
1.50 Other Research grants
Private / independent
USA
Pharmaxis Ltd Biotechnology - Therapeutics and
Diagnostics
24.00 Other Other Publicly listed on stock exchange
Australia
Kedalion Therapeutics
Biotechnology - Therapeutics and
Diagnostics
5.00 Series A / 1. Round
Equity (private)
Private / independent
USA
Akouos Biotechnology - Therapeutics and
Diagnostics
50.00 Series A / 1. Round
Equity (private)
Private / independent
USA
Credence MedSystems
Medical Technology 12.80 Series B / 2. Round
Equity (private)
Private / independent
USA
ARIDIS Pharmaceuticals, LLC
Biotechnology - Therapeutics and
Diagnostics
28.00 Other IPO Publicly listed on stock exchange
USA
PBD Biotech Biotechnology / R&D Services
0.51 Other Other Private / independent
United Kingdom
Tandem Diabetes Care, Inc.
Medical Technology 115.00 Other Other Publicly listed on stock exchange
USA
GT Biopharma, Inc Biotechnology - Therapeutics and
Diagnostics
5.14 00-Jan-00
Debt financing
Publicly listed on stock exchange
USA
Agilvax, Inc. Biotechnology - Therapeutics and
Diagnostics
2.30 Other Research grants
Private / independent
USA
DotBio Biotechnology - Therapeutics and
Diagnostics
2.30 0 Equity (private)
Private / independent
Singapore
Samumed LLC Biotechnology - Therapeutics and
Diagnostics
438.00 Other Other Private / independent
USA
Cure Genetics Co., Ltd. (CureGenetics)
Biotechnology - Therapeutics and
Diagnostics
17.00 Series A / 1. Round
n/a Private / independent
China (Mainland)
Surterra Wellness Biotechnology - other
65.00 Series C / 3. Round
Equity (private)
Private / independent
USA
GenomeUp Biotechnology / R&D Services
0.23 Other Other Private / independent
Italy
Adamis Pharmaceuticals Corporation
Biotechnology - Therapeutics and
Diagnostics
40.20 Other Post-IPO Publicly listed on stock exchange
USA
TherapeuticsMD, Inc
Pharma 90.00 Other Post-IPO Publicly listed on stock exchange
USA
Acer Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
46.00 Other Other Publicly listed on stock exchange
USA
Oxford BioTherapeutics Ltd
Biotechnology - Therapeutics and
Diagnostics
2.57 0 n/a Private / independent
United Kingdom
IMPACT Therapeutics, Inc.
Biotechnology - Therapeutics and
Diagnostics
30.00 Series C / 3. Round
n/a Private / independent
China (Mainland)
Calcivis Ltd Medical Technology 4.05 Other Equity (private)
Private / independent
United Kingdom
Karuna Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
42.00 Series A / 1. Round
Equity (private)
Subsidiary USA
Reviral Ltd Biotechnology - Therapeutics and
Diagnostics
55.00 Series B / 2. Round
Other Private / independent
United Kingdom
NED Biosystems Biotechnology - Therapeutics and
Diagnostics
2.00 Series B / 2. Round
Equity (private)
Private / independent
USA
Phico Therapeutics Ltd.
Biotechnology - Therapeutics and
Diagnostics
1.80 Other Research grants
Private / independent
United Kingdom
Ascletis Pharmaceuticals Co., Ltd.
Biotechnology - Therapeutics and
Diagnostics
400.00 00-Jan-00
IPO Publicly listed on stock exchange
China (Mainland)
Kiadis Pharma N.V. Biotechnology - Therapeutics and
Diagnostics
20.00 Other n/a Publicly listed on stock exchange
Netherlands
Arrowhead Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
10.00 Other Other Publicly listed on stock exchange
USA
